A detailed history of Segall Bryant & Hamill, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 134,937 shares of SWTX stock, worth $4.8 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
134,937
Previous 140,441 3.92%
Holding current value
$4.8 Million
Previous $5.29 Million 18.28%
% of portfolio
0.06%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$32.04 - $42.76 $176,348 - $235,351
-5,504 Reduced 3.92%
134,937 $4.32 Million
Q2 2024

Aug 14, 2024

BUY
$36.06 - $47.62 $5.06 Million - $6.69 Million
140,441 New
140,441 $5.29 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.22B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.